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Extraction Efficiency of
Extracellular MRI Contrast
Agents and Its Model-Dependent
Effects on Estimates of Myocardial Blood Flow
In their recent study, Cullen et al. (1) report on the highly relevant
determination of a perfusion reserve index with magnetic reso-
nance imaging (MRI) in patients with coronary artery disease.
Without wanting to detract from the fact that theirs is a valuable
study, we take issue with the negative appraisal of first-pass
imaging with rapid bolus injections.
Based on numerous studies with extravascular and intravascular
MRI contrast agents it has been shown that the best sensitivity to
changes in myocardial blood flow is observed with a rapid bolus
injection and imaging during the initial wash-in of contrast agent
(2). The investigators suggest that a slower injection and a
correspondingly lower temporal resolution (the authors report
acquisition of an image every six heart beats) are of practical
advantage. In fact, this forces them to determine blood flow
indirectly with the Kety model by measuring the product of
extraction efficiency (E) and myocardial blood flow (F) and to
assume that the extraction efficiency is unchanged for different
pathologies. The Kety model is most suitable for modeling the
kinetics of freely diffusible tracers because the extraction efficiency
can then be set to unity. For extracellular MRI contrast agents such
as Gd-DTPA, which are barrier-limited, the assumption that the
extraction remains constant is controversial. Several investigators
have shown that E varies with flow, and between normal and
ischemic/reperfused myocardium by as much as 100% (3,4). Data
by Watson et al. (5) comparing the FE product with blood flows
measured by positron emission tomography (PET) show that at
low flows the FE product is rather insensitive to changes in flow.
Furthermore, E is generally not constant during distribution of a
tracer, and the choice of an E value is by no means unambiguous.
The fact that the reported values of the perfusion reserve index,
calculated with the assumption of a constant E, agree in normal
healthy volunteers with previous PET studies is not sufficient to
validate the application of the Kety model in patients.
Although Cullen et al. (1) describe their MRI measurements as
first-pass studies, this does not seem to be appropriate when
images are acquired every six heart beats. In fact, the Kety model
may not fit well with data acquired in a true first-pass study owing
to the initially low extraction of contrast agent during wash-in.
The authors’ criticism (p. 1391) of previous first-pass studies (6)
because of use of a fast bolus injection is misleading. The perfusion
reserve estimate obtained in patients with microvascular dysfunc-
tion with such MRI first-pass studies was validated by comparison
to the coronary flow reserve (6). It remains to be shown that a
perfusion reserve index derived with the Kety model corresponds
under different pathophysiological conditions to the myocardial
blood flow reserve. In our opinion the first-pass technique is
preferred to determine myocardial blood flow and the myocardial
blood flow reserve.
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REPLY
I would like to respond to several issues raised by the letter of
Jerosch-Herold et al. First, I do not purport that a lower temporal
resolution of an image every six heart beats used in our study (1)
confers an advantage. This is a clear compromise between having
more slices and less data points on the first-pass transit curves,
which was necessitated by the hardware constraints we had at the
inception of this study. Although the use of an inversion-recovery
sequence results in relatively prolonged image acquisition times
even with the fastest magnetic resonance imaging (MRI) scanners,
the images are stable and of good quality for analysis. This is in
contrast to the saturation-recovery sequences used by Jerosch-
Herold (2), which may allow more of the heart to be imaged in less
time but in which the images are often of poor quality and subject
to artefacts. However, the slower injection technique used in our
study is an advantage over the power injections into the right
subclavian vein reported in other studies (2); this is because a
relatively invasive subclavian line is needed, which is less attractive
for patient and operator. Also, a power injector is required, which
is safe with magnetic fields and correspondingly expensive, whereas
our technique can be administered manually through a peripheral
vein.
Second, the question of whether the extraction efficiency (E)
remains constant or varies with myocardial flow (F) is controversial
and as yet remains a subject for further research. In support of
using the EF product (K1) for estimating flow, a recent study by
Vallee et al. (3) in a canine occluded coronary artery model
demonstrated that F measured with microspheres had a linear fit to
K1 for Gd-DTPA, (r 5 0.88). However, as the behavior of E is
uncertain at differing flow rates, the term “myocardial perfusion
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